Starling Oncology STLN
NASDAQ STLN
$5.95 -0.14 (-2.22%)
As of: Sep 3, 2026 · 3:37 PM EDT

Starling Oncology (STLN) Non-Current Debt (2020 - 2026)

Analysis

Starling Oncology (STLN) Non-Current Debt (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 HCA Healthcare 90.73 Bn 89.71 Bn 15.19 Bn 45.83 Bn
2 Tenet Healthcare 22.05 Bn 19.88 Bn 4.45 Bn 13.09 Bn
3 Encompass Health 12.13 Bn 12.00 Bn 1.34 Bn 2.60 Bn
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn 10.66 Bn
5 Universal Health Services 10.12 Bn 9.98 Bn 3.29 Bn 4.90 Bn
6 Ensign 9.97 Bn 9.64 Bn 306.24 Mn 135.56 Mn
7 Chemed 6.91 Bn 6.87 Bn 221.47 Mn 140.00 Mn
8 Pacs 6.73 Bn 6.57 Bn 338.46 Mn 238.71 Mn
9 Concentra Group Holdings Parent 4.30 Bn 4.14 Bn 192.10 Mn 1.56 Bn
10 Starling Oncology 613.55 Mn 572.46 Mn 27.17 Mn 79.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 79.87 Mn
Mar 31, 2026 78.61 Mn
Dec 31, 2025 77.40 Mn
Sep 30, 2025 76.20 Mn
Jun 30, 2025 75.02 Mn
Mar 31, 2025 73.89 Mn
Dec 31, 2024 93.13 Mn
Sep 30, 2024 91.54 Mn
Jun 30, 2024 89.95 Mn
Mar 31, 2024 88.39 Mn
Dec 31, 2023 86.83 Mn
Sep 30, 2023 85.25 Mn
Jun 30, 2023 83.69 Mn
Mar 31, 2023 82.14 Mn
Dec 31, 2022 80.62 Mn
Sep 30, 2022 79.07 Mn
Dec 31, 2020 6.56 Mn